Cancer Advisor

Published by: Dr William Makis on X.com (May 4, 2026 & Aug 9, 2026) | Edited and Reviewed by: OneDayMD Editorial Team Important Medical Disclaimer This article is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Repurposed drugs like ivermectin and fenbendazole are not approved by the FDA or any major regulatory body for cancer. Self-medication can cause serious side effects including liver toxicity, drug interactions, or delayed standard care. Always consult a qualified oncologist before considering any off-label protocol. Individual results vary widely and often reflect combined therapies. The case below is anonymized from a publicly shared patient report; outcomes are not guaranteed. Case Presentations Case 1 - 2026:  63 year old woman in URUGUAY with Lung Cancer Recurrence reports after 5 months: No evidence of disease (NED) Dr William Makis posted on   X.com   in August 2026: IVERMECTIN and MEBENDAZO...

The Shift to Personalized Cancer Care Precision medicine, powered by advances in genomics , is revolutionizing how cancer is diagnosed, treated, and even prevented. Unlike the traditional “one-size-fits-all” approach, precision medicine tailors prevention and treatment strategies to each person’s unique genetic makeup, environment, and lifestyle. This shift is leading to more effective therapies, fewer side effects, and earlier interventions ( 1 ,  2 ,  3 ). Key Innovations Driving Change Comprehensive Tumor Profiling: Oncologists now routinely order detailed genetic analyses of tumors, identifying specific mutations that drive cancer growth. This allows for highly targeted therapies that are more likely to be effective for each individual patient ( 1 ,  4 ,  2 ). Targeted Therapies:  Drugs are developed to target specific genetic mutations or proteins found in cancer cells. For example, HER2-targeted therapies (like trastuzumab and tucatinib) have transformed b...